MSB 0.42% $1.20 mesoblast limited

Ann: Remestemcel-L for COVID-19 MIS-C published in Pediatrics, page-185

  1. 2,261 Posts.
    lightbulb Created with Sketch. 367
    I disagree they have provided at least 5 level 2b studies that the treatment works. Thats enough to change clincial practice and get FDA approval in many drugs to date. besides about 20% of medicine is actually properly evidenced based... and that hasnt stopped you cutting people open and poisoning them for years. Not intentionally of course but... human factors
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
$1.20
Change
0.005(0.42%)
Mkt cap ! $1.358B
Open High Low Value Volume
$1.18 $1.20 $1.18 $677.4K 570.2K

Buyers (Bids)

No. Vol. Price($)
4 18687 $1.20
 

Sellers (Offers)

Price($) Vol. No.
$1.20 185885 23
View Market Depth
Last trade - 10.19am 15/07/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.